Jeremy Barr, PhD

Monash University; Barr Lab

Jeremy completed his PhD in microbiology at The University of Queensland in 2011. He then moved to San Diego, USA to complete a postdoctoral position under the tutelage of Prof. Forest Rohwer at San Diego State University. While there he studied the interactions of bacteriophage with mucosal surfaces and was involved in a world-first phage therapy case treating a patient with disseminated, multidrug-resistant infection. In 2016, he joined Monash University's School of Biological Sciences where he is currently an Associate Professor and Group Leader. His research group studies bacteriophages and their interactions with their bacterial hosts and the human body. In 2020, he joined the Centre to Impact AMR where he leads the Monash Phage Foundry as an in-house manufacturing facility. In 2024, he was awarded a prestigious NHMRC Investigator Fellow L1 in recognition of their translational work using phage therapy to combat antimicrobial resistance.

Loading issues…

Why all phage researchers need to be in Australia this JulyThis week we've got an interview with Jeremy Barr on what to expect this year at the Viruses of Microbes conference in Cairns, Australia! From Great Barrier Reef, to crocodile jet ski stories, to special ways they're making the conference…Issue 263May 3, 2024Jessica Sacher, Jeremy Barr

Source-reported research

Research context

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. As of 2026-10-22. Reviewed 2026-10-22.

Collected publications span phage isolation from canola rhizosphere bacteria, clinical phage-therapy failure, and gut-phage associations with Crohn’s disease. [1] [2] [3]

Sources and review

doi.org Observed 2026-10-22. Abstract/title supporting publication-history context
doi.org Observed 2026-10-22. Abstract/title supporting publication-history context
doi.org Observed 2026-10-22. Abstract/title supporting publication-history context

Reviewed by ai:codex-identities-ce68394c9be2. Reviewed every cited source quote and accepted paper link. This is dated publication-history context, with peripheral or predicted evidence explicit, not current work/employment or individual contribution. Draft Codex delegation gpt-6-luna/xhigh; named coordinator final review.

Source-selected papers

AI-assisted source report. It may be incomplete or mistaken and may not reflect current work. Reviewed 2026-10-22.

Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure. (2026)
Listed author: J. J. Barr. Selection: recent. 2026-04-24; Directly examines a clinical phage-therapy failure and possible roles for anti-prophage antibodies and bacterial heteroresistance. [1] [3] [2] [4] [5]
Gut DNA virome enterotype dictates inflammation heterogeneity through tuning the phage-bacteria-sphingosine-intestine axis in Crohn's disease. (2026)
Listed author: Jeremy J. Barr. Selection: recent. 2026-02-09; Directly links gut bacteriophages, Bacteroides, and Crohn’s disease inflammation. [6] [8] [7] [9] [10]
Isolation and characterisation of virulent bacteriophage targeting canola rhizosphere bacteria Klebsiella grimontii and Bacillus sp. (2026)
Listed author: Jeremy J. Barr. Selection: recent. 2026-06-01; Reports isolation and characterization of virulent phages from canola rhizosphere bacteria. [11] [13] [12] [14] [15]

Sources and review

doi.org Observed 2026-10-22. Accepted exact work native ID
doi.org Observed 2026-10-22. Own exact DOI
doi.org Observed 2026-10-22. Printed accepted author slot
doi.org Observed 2026-10-22. Source abstract/title: phage relevance
doi.org Observed 2026-10-22. Source publication clock
doi.org Observed 2026-10-22. Accepted exact work native ID
doi.org Observed 2026-10-22. Own exact DOI
doi.org Observed 2026-10-22. Printed accepted author slot
doi.org Observed 2026-10-22. Source abstract/title: phage relevance
doi.org Observed 2026-10-22. Source publication clock
doi.org Observed 2026-10-22. Accepted exact work native ID
doi.org Observed 2026-10-22. Own exact DOI
doi.org Observed 2026-10-22. Printed accepted author slot
doi.org Observed 2026-10-22. Source abstract/title: phage relevance
doi.org Observed 2026-10-22. Source publication clock

Reviewed by ai:codex-identities-ce68394c9be2. Reviewed exact accepted authorship/DOI and date/relevance passages. The 24-month publication selections do not claim complete or greatest-work coverage. Broad bacterial-host environmental viromics is included with predicted-host wording. Draft Codex delegation gpt-6-luna/xhigh; coordinator reviewed and retained changes separately.